163 related articles for article (PubMed ID: 35757685)
1. Immunologic Biomarkers in Peripheral Blood of Persons With Tuberculosis and Advanced HIV.
Queiroz ATL; Araújo-Pereira M; Barreto-Duarte B; Gomes-Silva A; Costa AG; Andrade AMS; Miguez-Pinto JP; Spener-Gomes R; Souza AB; Benjamin A; Sant'Anna F; Figueiredo MC; Mave V; Salgame P; Ellner JJ; Sterling TR; Cordeiro-Dos-Santos M; Andrade BB; Rolla VC
Front Immunol; 2022; 13():890003. PubMed ID: 35757685
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Determine TB-LAM Ag to detect TB in HIV infected patients associated with diagnostic methods used in Brazilian public health units.
Benjamin A; Cavalcante SC; Jamal LF; Arakaki-Sanchez D; de Lima JN; Pilotto JH; de Oliveira Junior FI; Souza TNL; Lourenço MC; de Mello MB; do Brasil PEAA; Barreira D; Rolla V
PLoS One; 2019; 14(9):e0221038. PubMed ID: 31550246
[TBL] [Abstract][Full Text] [Related]
3. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV.
Farr K; Ravindran R; Strnad L; Chang E; Chaisson LH; Yoon C; Worodria W; Andama A; Ayakaka I; Bbosa Nalwanga P; Byanyima P; Kalema N; Kaswabuli S; Katagira W; Aman KD; Musisi E; Tumwine NW; Sanyu I; Ssebunya R; Davis JL; Huang L; Khan IH; Cattamanchi A
PLoS One; 2018; 13(10):e0206119. PubMed ID: 30352099
[TBL] [Abstract][Full Text] [Related]
5. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
[TBL] [Abstract][Full Text] [Related]
6. Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study.
Schutz C; Barr D; Andrade BB; Shey M; Ward A; Janssen S; Burton R; Wilkinson KA; Sossen B; Fukutani KF; Nicol M; Maartens G; Wilkinson RJ; Meintjes G
PLoS Med; 2019 Jul; 16(7):e1002840. PubMed ID: 31276515
[TBL] [Abstract][Full Text] [Related]
7. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
[TBL] [Abstract][Full Text] [Related]
8. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
10. Integrative Multi-Omics Reveals Serum Markers of Tuberculosis in Advanced HIV.
Krishnan S; Queiroz ATL; Gupta A; Gupte N; Bisson GP; Kumwenda J; Naidoo K; Mohapi L; Mave V; Mngqibisa R; Lama JR; Hosseinipour MC; Andrade BB; Karakousis PC
Front Immunol; 2021; 12():676980. PubMed ID: 34168648
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis distorts the inhibitory impact of interleukin-10 in HIV infection.
Chetty S; Porichis F; Govender P; Zupkosky J; Ghebremichael M; Pillay M; Walker BD; Ndung'u T; Kaufmann DE; Kasprowicz VO
AIDS; 2014 Nov; 28(18):2671-6. PubMed ID: 25211438
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
Lawn SD; Kerkhoff AD; Vogt M; Wood R
Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
[TBL] [Abstract][Full Text] [Related]
14. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
Mavenyengwa RT; Shaduka E; Maposa I
Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Cepheid's Xpert MTB/Rif test on pleural fluid in the diagnosis of pleural tuberculosis in a high prevalence HIV/TB setting.
Lusiba JK; Nakiyingi L; Kirenga BJ; Kiragga A; Lukande R; Nsereko M; Ssengooba W; Katamba A; Worodria W; Joloba ML; Mayanja-Kizza H
PLoS One; 2014; 9(7):e102702. PubMed ID: 25051491
[TBL] [Abstract][Full Text] [Related]
17. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
[TBL] [Abstract][Full Text] [Related]
18. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome.
Chakrabarti LA; Boucherie C; Bugault F; Cumont MC; Roussillon C; Breton G; Patey O; Chêne G; Richert L; Lortholary O;
AIDS; 2014 Jul; 28(11):1593-602. PubMed ID: 24865974
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
